"at very best, a guess" Enraged...That pretty much sums up Bioniche.
Thank goodness that there are several interested parties and lots going on behind the scenes. If it weren't for those two pillars of definitive information, that have carried BNC shareholders for the last half decade of decline, with brief periods of further decline, we could be trading below 50 cents.
Just know that they too and disappointed in the share price, but things should turn around once more clarity is provided on a Urocidin partner and Econiche is subsidized...or something along those lines.